Zinc oxide nanoparticles (ZnONPs) of average diameter of 45 ? 5.0 nm
were prepared using chemical reduction method and characterized by UV-Visible
spectroscopy, Scanning electron microscopy (SEM), Atomic force microscopy
(AFM), X-Ray diffraction (XRD) and Fourier Transmission Infrared spectroscopy
(FTIR). To test the ability of ZnONPs to ameliorate antihyperglycemic and the
oxidative stress status resulted in experimental diabetic rats induced by
alloxan, sixty male albino rats with weight 220 ? 25 grams and age of 9 months
were used in experimental design. Ten of them were served as control group and
fifty rats were injected with alloxan at the single intraperitoneal dose of 150
mg/kg. Then, subdivided into, diabetic, diabetic rats + ZnONPs I, received
single daily dose of 2.5 mg/kg b.w ZnONPs in suspension. Diabetic rats + ZnONPs
II, received a single daily dose of 5.0mg/kg b.w ZnONPs in suspension ,
diabetic rats + ZnONPs III, received a single daily dose of 10 mg/kg b.w ZnONPs
in suspension, diabetic rats + insulin; received a single daily subcutaneous
dose of insulin 2U/kg b.w. At the end of experimental time(60 days) the blood
glucose, serum insulin,glycoslated HbA1c, lipid peroxidation marker,
malondialdehyde (MDA), reduced glutathione (GSH) and serum activities of
superoxide dismutase (SOD), glutathione peroxidase (GPx) and Catalase (Cat)
were determined. Results showed a significant alteration in the activities of
SOD, GPx, CAT, MDA Insulin, HbA1c and FBS in animals treated of ZnONPs,
compared with diabetic or diabetic + insulin group and their control group. The
profound control of ZnONPs over the anti-oxidant enzymes in diabetic rats to
normal, by inhibition of lipid peroxidation and reactive oxygen species
generation during hyperglycemia evidence their antioxidant effect during diabetes.
The administration of ZnONPs at 10 mg/kg b.w exhibited an insistent control
over the blood glucose level, lipids and serum biochemical profiles in diabetic
rats near to the control group provokes their effective role in controlling and
increasing the organ functions for better utilization of blood glucose.
Histopathological studies revealed the non-toxic and protective effect of the
ZnONPs over the vital organs and can be used to ameliorate the hyperglycemia
and oxidative stress status. - See more at:
No comments:
Post a Comment